Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma

International Journal of Cancer

Volumn 65, Issue 1, 1996, Pages 1-5

  Karlsson, Margareta ^a   Jungnelius, Ulf ^c   Aamdal, Steinar ^e   Boeryd, Bernt ^a   Carstensen, John ^b   Kågedal, Bertil ^a   Westberg, Ronny ^d   Wingren, Sten ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d BRISTOL MYERS SQUIBB   (United States)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DACARBAZINE; VINDESINE;

ARTICLE; CELL CYCLE S PHASE; DISSEMINATED CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; PLOIDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DACARBAZINE; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PLOIDIES; REGRESSION ANALYSIS; S PHASE; SURVIVAL ANALYSIS; VINDESINE;

EID: 0030054218     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960103)65:1<1::AID-IJC1>3.0.CO;2-6     Document Type: Article

References (25)

1. ABE, S., TSUNETA, Y., MAKIMURA, S., ITABASHI, K., NAGAI, T. and KAWAKAMI, Y., Nuclear DNA content as an indicator of chemosensitivity in small-cell carcinoma of the lung. Anal. quant. Cytol. Histol., 9, 425-428 (1987).
2. BAISCH, H., GÖHDE, W. and LINDEN, W.A., Analysis of PCP-data to determine the fraction of cells in the various phases of the cell cycle. Rad. environ. Biophys., 12, 31-39 (1975).
3. BARTKOWIAK, D., SCHUMANN, J., OTTO, F.J., LIPPOLD, A. and DREPPER, H., DNA flow cytometry in the prognosis of primary malignant melanoma. Oncology, 48, 39-43 (1991).
4. BONNADONNA, G., VALAGUSSA, P., TANCINI, G., ROSSI, A., BRAMBILLA, C., ZAMBETTI, M., BIGNAMI, P., DI FRONZO, G. and SILVESTRINI, R., Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. NCI Monogr., 1, 45-49 (1986).
5. BÜCHNER, T., HIDDEMANN, W., WÖRMANN, B., KLEINEMEIER, B., SCHUMANN, J., GÖHDE, W., RITTER, J., MÜLLER, K-M., VONBASSEWITZ, D.B., ROESSNER, A. and GRUNDEMANN, E., Differential pattern of DNA-aneuploidy in human malignancies. Path. Res. Pract., 179, 310-317 (1985).
6. DYSON, J.E.D., JOSLIN, C.A.F., ROTHWELL, R., QUIRKE, P., KHOURY, G.G. and BIRD, C.C., Flow cytofluorometric evidence for the differential radio-responsiveness of aneuploid and diploid cervix tumours. Radiother. Oncol., 8, 263 (1987).
7. FRANZEN, G., OLOFSSON, J., TYTOR, M., KLINTENBERG, C. and RISBERG, B., Preoperative irradiation in oral cavity carcinoma. A study with special reference to DNA pattern histological response and prognosis. Acta oncol., 26, 349-355 (1987).
8. GOLDSMITH, M.M., CRESSON, D.S., POSTMA, D.S., ASKIN, F.B. and PILLSBURY, H.C., Significance of ploidy in laryngeal cancer. Ann. J. Surg., 152, 396-402 (1986).
9. HANSSON, J., Mechanisms of tumour cell resistance to cancer chemotherapeutic drugs. Europ. J. Surg. (Suppl.), 561, 35-44 (1991).
10. JACOBSEN, A.B., FOSSÅ, S.D., LUNDE, S., MELVIK, J.E. and PETTERSEN, E.O., Flow cytometric DNA measurements in paraffin-embedded bladder carcinoma tissue before and after precystectomy radiotherapy. Radiother. Oncol., 10, 149-155 (1987).
11. KARLSSON, M., BOERYD, B., CARSTENSEN, J., KÅGEDAL, B., TERNESTEN BRATEL, A. and WINGREN, S., DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease. Brit. J. Cancer, 67, 134-138 (1993).
12. KARLSSON, M., BOERYD, B., CARSTENSEN, J., KÅGEDAL, B. and WINGREN, S., DNA ploidy and S-phase in primary malignant melanomas and their regional metastases. Melanoma Res., 4, 47-51 (1994).
13. KARLSSON, M., BOERYD, B., CARSTENSEN, J., KÅGEDAL, B. and WINGREN, S., DNA ploidy and S-phase fraction as prognostic factors in patients with uveal melanomas. Brit. J. Cancer, 71, 177-181 (1995).
14. KHEIR, S.M., BINES, S.D., VONROENN, J.H., SOONG, S.-J., URIST, M.M. and COON, J.S., Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann. Surg., 207, 455-461 (1988).
15. KLEIN, F.A., Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry, preliminary report. Int. J. Radiat. Oncol., 9, 487-491 (1983).
16. LOOK, A.T., HAYES, F.A., NITSCHKE, R., MCWILLIAMS, N.B. and GREEN, A.A., Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. New Engl. J. Med., 311, 231-235 (1984).
17. MUHONEN, T., PYRHÖNEN, S., LAASONEN, A., ASKO-SELJAVAARA, S. and FRANSSILA, K., DNA aneuploidy and low S-phase fraction as favourable prognostic signs in metastatic melanoma. Brit. J. Cancer, 64, 749-752 (1991).
18. REMVIKOS, Y., BEUZEBOC, P., ZAJDELA, A., VOILLEMOT, N., MAGDELÉNAT, H. and POUILLART, P., Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J. nat. Cancer Inst., 81, 1383-1387 (1989).
19. SCHUTTE, B., REYNDERS, M.M.J., BOSMAN, F.T. and BLIJHAM, G.H., Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue. Cytometry, 6, 26-30 (1985).
20. SPYRATOS, F., BRIFFOD, M., TUBIANA-HULIN, M., ANDRIEU, C., MAYRAS, C., PALLUD, C., LASRY, S. and ROUESSE, J., Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumour regression and short-term follow-up. Cancer, 69, 470-475 (1992).
21. STÅL, O., SKOOG, L., RUTQVIST, L.-E., CARSTENSEN, J.M., WINGREN, S., SULLIVAN, S., ANDERSSON, C., DUFMATS, M. and NORDENSKJÖLD, B., S-phase fraction and survival benefit from adjuvant chemotherapy of breast cancer. Brit. J. Cancer, 70, 1258-1262 (1994).
22. SULKES, A., LIVINGSTON, R.B. and MURPHY, W.K., Tritiated thymidine labeling index and response in human breast cancer. J. nat. Cancer Inst., 62, 513-515 (1979).
23. VINDELØV, L.L., CHRISTENSEN, I.L. and NISSEN, N.I., A detergenttrypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry, 3, 323-327 (1983).
24. VINDELØV, L.L., HANSEN, H.H., GERSEL, A., HIRSSH, F.R. and NISSEN, N.I., Treatment of small-cell carcinoma of the lung monitored by sequential flow cytometric DNA analysis. Cancer Res., 42, 2499-2505 (1982).
25. WINGREN, S., STÅL, O. and NORDENSKJÖLD, B., Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. Brit. J. Cancer, 69, 546-549 (1994).